|
|
|
|
|
|
|
|
|
01.07.25 - 08:03
|
KKR Makes Second Residential Investment in Stockholm with Three Asset Multifamily Development in Täby (Business Wire)
|
|
|
STOCKHOLM--(BUSINESS WIRE)--KKR, a leading global investment firm, today announced the agreement with leading Swedish developer Reliwe for the forward funding of a new multifamily development in Täby, one of Stockholm's most sought-after municipalities. The transaction marks KKR's second residential investment in Sweden's capital region since the beginning of 2025.
The project in Täby comprises three residential assets with a total of 325 units and approximately 15,300 square meters of lettable area, expected to be completed in phases between 2026 and 2028. Located just 14 kilometers from Stockholm city center, the asset offers excellent public transport connectivity via a nearby train station, providing access to central Stockholm in under 20 minutes. The development is situated adjacent to Täby Centrum, one of the city's leading shopping centers, and is designed to meet high sustainability and architectural standards.
In February, KKR announced its investment in three multifamily properties in Ha...
|
|
|
|
|
01.07.25 - 00:30
|
15 Analysts Assess KKR: What You Need To Know (Benzinga)
|
|
|
Latest Ratings for KKR
DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Deutsche BankMaintainsBuy Jan 2022Morgan StanleyMaintainsEqual-Weight
View More Analyst Ratings for KKR
View the Latest Analyst Ratings
read more...
|
|
|
|
|
29.06.25 - 23:24
|
Torrent in Rs 18,000 crore deal, 2nd largest in pharma sector (Times of India)
|
|
|
Torrent Pharma is set to acquire a controlling stake in JB Chemicals & Pharmaceuticals for approximately Rs 18,000 crore, marking the second-largest pharma deal in India. The acquisition involves purchasing a 46.4% stake from KKR, followed by an open offer to public shareholders. This deal will create India's second most valued pharma company, with substantial revenue and a top-five ranking....
|
|
|
|
|
|
|
29.06.25 - 17:54
|
Torrent Pharma to Acquire Controlling Stake in J. B. Chemicals & Pharmaceuticals from KKR (Business Wire)
|
|
|
Acquisition to be followed by merger; strengthens Torrent's IPM market presenceMUMBAI, India--(BUSINESS WIRE)--Torrent Pharmaceuticals Limited (“Torrent”) and global investment firm KKR today announced that Torrent has entered into definitive agreements to acquire controlling stake in J. B. Chemicals and Pharmaceuticals (“JB Pharma”) from KKR at an Equity Valuation of INR 25,689 crores (on fully diluted basis), followed by a merger of the two entities. The transaction marks a significant step in Torrent's ambition to create a future-ready, diversified healthcare platform combining a deep chronic segment heritage with emerging international CDMO capabilities.
The transaction will be executed in 2 phases:
Acquisition of 46.39% equity stake (on a fully diluted basis) through a Share Purchase Agreement (“SPA”) at a consideration of INR 11,917 crores (INR 1,600 per share) followed by a mandatory open offer to acquire up to 26% of JB Pharma shares from public shareholders at an open offer price of...
|
|
|
|
|
|
|
27.06.25 - 06:48
|
Germany′s Plans Are Big, But Not Big Enough, KKR′s Vincent Policard Says (Bloomberg)
|
|
|
The German cabinet has approved plans to spend €500B on infrastructure over the next 12 years, but KKR's Vincent Policard says it's not enough. KKR has invested billions in Germany over the past few years, and Policard says private capital will be key. He spoke to Bloomberg's Tom Mackenzie on "Daybreak Europe" on June 25. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
